Ninety-day mortality following transoral robotic surgery or radiation at Commission on Cancer-accredited facilities.

James R Janopaul-NaylorManali RupjiRachel A TobilloJoshua W LorenzJeffrey M SwitchenkoSibo TianAzeem S KakaDavid C QianAshley J SchlafsteinConor E SteuerJill S RemickSoumon RudraMark W McDonald Nabil F SabaWilliam A StokesMihir R PatelJames E Bates

Published in: Head & neck (2022)

There is minimal difference between 90-day mortality in patients treated with TORS or radiotherapy for early-stage OPSCC. While overall rates are low, for patients with expectation of cure, work is needed to identify optimal treatment.

Keyphrases

early stage
cardiovascular events
papillary thyroid
risk factors
radiation induced
radiation therapy
sentinel lymph node
cardiovascular disease
coronary artery disease